# 04_QA_REPORT

# Quality Assurance Report

## Identity
| Field | Value |
|---|---|
| QA Report ID | QA-PP-0167 |
| Population Package | PP-0167 — Pernicious Anemia and Gastric Cancer |
| Version | 1.0.0 |
| QA Status | PASS — GOLD |

# Layer 1 — Content QA
| Criterion | Result |
|---|---|
| Single educational question | PASS |
| Scope respected | PASS |
| Pernicious anemia defined | PASS |
| Gastric-cancer risk association covered | PASS |
| Screening implication covered | PASS |
| Patient explanation included | PASS |
| Misconceptions addressed | PASS |
| Knowledge blocks complete | PASS |

# Layer 2 — Clinical QA
| Criterion | Result |
|---|---|
| Increased gastric-cancer risk correctly represented | PASS |
| Risk not equated with cancer | PASS |
| Intrinsic-factor/B12 relationship correctly bounded | PASS |
| Autoimmune gastric context appropriately bounded | PASS |
| Atrophic gastritis delegated to PP-0165 | PASS |
| Intestinal metaplasia delegated to PP-0166 | PASS |
| Screening protocol delegated to PP-0170+ | PASS |
| No hereditary implication | PASS |
| No unsupported individual risk estimate | PASS |
| No universal endoscopy schedule invented | PASS |

# Layer 3 — Educational QA
| Criterion | Result |
|---|---|
| Plain language | PASS |
| Patient-centered explanation | PASS |
| Risk vs diagnosis distinction | PASS |
| Risk vs inevitability distinction | PASS |
| Common misconceptions addressed | PASS |
| No individualized medical advice | PASS |

# Layer 4 — Governance QA
| Criterion | Result |
|---|---|
| Approved Decision Batch respected | PASS |
| Source-First rule followed | PASS |
| Adjacent overlap reviewed | PASS |
| Gold structure respected | PASS |
| Four artifacts completed | PASS |
| Version 1.0.0 | PASS |
| Evidence traceability documented | PASS |
| Knowledge Graph documented | PASS |
| Integration-ready | PASS |

# Clinical Safety Review
- No treatment prescription: **PASS**
- No universal screening recommendation: **PASS**
- No individualized risk calculation: **PASS**
- No hereditary diagnosis from pernicious anemia: **PASS**
- No unsupported surveillance interval: **PASS**
- Evidence gaps explicitly retained: **PASS**

# Educational Boundary Review
The package remains focused on **pernicious anemia as a gastric-cancer risk condition**.

It does not duplicate:
- atrophic-gastritis core content;
- intestinal-metaplasia core content;
- H. pylori eradication/prevention;
- hereditary gastric-cancer packages;
- detailed gastric-cancer screening protocols;
- gastric adenoma management;
- B12 treatment.

# Boundary

**Core =** pernicious anemia definition, intrinsic-factor/B12 relationship, pernicious anemia as a gastric-cancer risk condition, autoimmune/gastric mucosal context, distinction between increased risk and inevitable cancer, relationship with atrophic gastric disease and intestinal metaplasia at the conceptual level, why pernicious anemia may place selected patients in a higher-risk group for gastric-cancer screening; **Supporting =** stomach-surgery context, other gastric-cancer risk factors, upper-endoscopy concept, family-history context, general long-term follow-up implications; **Explicitly Excluded =** detailed vitamin B12 treatment, autoimmune-gastritis diagnostic/antibody algorithms, detailed atrophic-gastritis management, detailed intestinal-metaplasia classification/surveillance, universal endoscopy intervals, gastric neuroendocrine-tumor management, hereditary gastric-cancer assessment, germline/cascade testing, gastric adenoma management, individualized absolute-risk calculation; **Delegated-to PP =** PP-0165, PP-0166, PP-0160, PP-0161, PP-0155, PP-0169, PP-0170, PP-0171, PP-0149–PP-0159, Gastric Cancer Screening, Vitamin B12/Pernicious Anemia management.

# Final Quality Decision

## PASS

PP-0167 satisfies the approved Decision Batch, Gold Population Package requirements, Source-First evidence rules, clinical-safety rules, and adjacent-package boundary requirements.

# QA Final Status

# PASS — GOLD — READY FOR INTEGRATION
